Le Lézard
Classified in: Sports and recreation, Covid-19 virus
Subjects: TDS, MAT

PURA Enjoys Exceptional EVERx CBD Sport Water Coverage at Arnold 2020


DALLAS, March 11, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today announced garnering exceptional coverage for its EVERx CBD Sports Water last week at Arnold Schwarzenegger's Arnold Sports Festival in Columbus, Ohio. The Arnold Classic cooperated with the State of Ohio by limiting attendance at this year's event in light of Coronavirus concerns. The event operators worked tirelessly to ensure the event was executed in keeping with the highest competitive standards while also maintaining the highest safety standards. At the same time, PURA thanks the event operators for meeting the expectations of event sponsors and participants. PURA could not be happier with the coverage EVERx enjoyed at this year's event.

EVERx was introduced for the first time nearly three years ago at the Arnold Sports Festival. EVERx has since expanded its Arnold Sports Festival marketing globally participating at Arnold events not just in the United States, but in Africa and Europe as well. EVERx has become the leading CBD infused beverage in the sports nutrition market sector. EVERx now has distribution in Europe, Latin America and Africa in addition to within the United States.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley
[email protected]
+1-(800)-861-1350

SOURCE Puration, Inc.


These press releases may also interest you

at 13:13
E-Textile Market is Segmented by Type (Passive Electronic Textiles, Active Electronic Textiles, Ultra-Electronic Textiles), by Application (Military Uses, Civil Uses, Healthcare Uses). The Global E-Textile Market size is expected to reach USD 5238.3...

at 13:00
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 29, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II...

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 10:50
The "North America Dry Mix Mortar Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America)" report has been added to ResearchAndMarkets.com's offering....

at 09:00
Carbon Streaming Corporation (Cboe CA: NETZ) ("Carbon Streaming" or the "Company") provides an update on the Rimba Raya Project ("Rimba Raya" or the "Project"). The Company has learned of two third-party media reports that claim PT Rimba Raya...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...



News published on and distributed by: